New PET tracer could sharpen cancer detection
NCT ID NCT07708103
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This early-phase study tests a new radioactive tracer called [68Ga]Ga-FFD for PET imaging in healthy volunteers and people with solid tumors. The goal is to see if it is safe, where it goes in the body, and how well it spots tumors compared to standard imaging. Researchers will also measure radiation exposure and check for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a gallium-68-labeled PET radiotracer called [68Ga]Ga-FFD
- What this could lead to
- If successful, this tracer could improve detection of solid tumors, potentially leading to more accurate diagnosis and treatment planning.
- What could go wrong
- This is a very early, small study (12 participants) focused on safety and imaging properties, not treatment. The tracer may not prove better than existing methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Union Hospital, Huazhong University of Science and Technology
Wuhan, Hubei, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- ECMO in kids with cancer: a closer look at survival and risks
- Double-Drug attack on Hard-to-Treat cancers
- Engineered immune cells take on Hard-to-Treat cancers
- Cancer drug pralsetinib may change how the body processes other medications
- Genetic roadmaps for advanced cancer: study tests whether expert navigation boosts targeted therapy use
- New imaging agent aims to light up hidden tumors